Version of Record online: 8 JAN 2013
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 57, Issue 2, pages 625–636, February 2013
How to Cite
Wahl, K., Siegemund, M., Lehner, F., Vondran, F., Nüssler, A., Länger, F., Krech, T., Kontermann, R., Manns, M. P., Schulze-Osthoff, K., Pfizenmaier, K. and Bantel, H. (2013), Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib. Hepatology, 57: 625–636. doi: 10.1002/hep.26082
Potential conflict of interest: Drs. Kontermann and Pfizenmaier consult for and received grants from Biontech.
This study was supported by the Deutsche Forschungsgemeinschaft (SFB Transregio 77, SFB 685, and SFB 773) and BMBF (project no.: 0315-280A; FORSYS-Partner “Predictive Cancer Therapy”).
- Issue online: 5 FEB 2013
- Version of Record online: 8 JAN 2013
- Accepted manuscript online: 18 SEP 2012 06:12AM EST
- Manuscript Accepted: 4 SEP 2012
- Manuscript Received: 19 MAY 2012
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.